Cetrorelix Acetate Kit
Product Images NDC 65219-292

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Cetrorelix Acetate (NDC 65219-292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cetrorelix-spl-structure (Cet05 0000 01)

Chemical structure diagram of cetrorelix acetate showing its molecular composition, including rings, amide bonds, and functional groups, as typically represented for the peptide drug cetrorelix acetate.*

FDA Label Image

Fresnius Kabi Logo (Cet05 0000 02)

FDA Label Image

Cetrorelix-spl-fig.1 (Cet05 0000 03)

An instructional illustration showing two hands being washed under running water, with water droplets depicted to indicate rinsing. The image emphasizes hand hygiene.*

FDA Label Image

Cetrorelix-spl-fig.2 (Cet05 0000 04)

cetrorelix acetate kit packaging showing a small vial with a label, a syringe, two needles, and a sealed pouch on a plain background. The kit components are arranged together, illustrating a complete dosing set.*

FDA Label Image

Cetrorelix-spl-fig.3 (Cet05 0000 05)

An instructional diagram showing how to open a vial by first removing the protective cap by pulling it upward, then lifting an additional seal off the vial top. The image depicts two steps for vial preparation, likely related to the cetrorelix acetate kit.*

FDA Label Image

Cetrorelix-spl-fig.4 (Cet05 0000 06)

An instructional illustration showing a syringe component being detached or manipulated, with an arrow indicating a twisting or turning motion from one part of the syringe kit to another, likely part of the assembly or preparation process for use.*

FDA Label Image

Cetrorelix-spl-fig.5 (Cet05 0000 07)

An instructional illustration showing a vial and a syringe, with an arrow indicating the motion of drawing liquid from the vial into the syringe. This image likely depicts a step in preparing the cetrorelix acetate kit for use.*

FDA Label Image

Cetrorelix-spl-fig.6 (Cet05 0000 08)

An instructional line drawing showing a hand holding a vial and another hand using a syringe needle to draw liquid from the vial. The image illustrates the process of vial medication preparation, likely for cetrorelix acetate injection kit by Fresenius Kabi USA, LLC.*

FDA Label Image

Cetrorelix-spl-fig.7 (Cet05 0000 09)

An instructional diagram showing the setup of a cetrorelix acetate kit, including a vial connected to a syringe with an arrow indicating downward assembly or mixing action.*

FDA Label Image

Cetrorelix-spl-fig.8 (Cet05 0000 10)

An instructional diagram showing the assembly process of a syringe and needle. The illustration depicts arrows indicating how to attach the needle to the syringe for injection preparation.*

FDA Label Image

Cetrorelix-spl-fig.9 (Cet05 0000 11)

An instructional illustration showing a syringe with a needle cap being removed (indicated by an arrow pointing upward). The image appears to demonstrate the first step in preparing an injection, part of a kit for cetrorelix acetate by Fresenius Kabi USA, LLC.*

FDA Label Image

10 (Cet05 0000 12)

An instructional illustration showing two steps: the left side depicts a hand holding an object over an open top of a container, and the right side shows a hand holding a syringe, with a cap being removed or attached. This likely demonstrates preparation or administration steps for a medication kit.*

FDA Label Image

Cetrorelix-spl-fig.11 (Cet05 0000 13)

An instructional black and white line drawing showing a hand holding a syringe above a container labeled 'BIOHAZARD.' The syringe appears to be in the process of being placed into the biohazard disposal container.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Cetrorelix Acetate Single-Dose Vial Label)

Label for Cetrorelix Acetate for Injection 0.25 mg per vial, a sterile, single-dose vial intended for subcutaneous use only. The label includes storage instructions to refrigerate at 2-8°C and protect from light. The product is manufactured for Fresenius Kabi USA, LLC, made in India.*

FDA Label Image

Pdp Info – Cetrorelix Acetate For Injection 286701 Pfs (Cet05 0000 15)

Label for 1 mL Prefilled Sterile Water for Injection, USP manufactured for Fresenius Kabi USA, LLC, Lake Zurich, IL. The product is made in India. The label includes an NDC number partially visible as 65219-286-01 and barcode.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Cetrorelix Acetate Blister Foil Label)

Packaging label for Cetrorelix Acetate for Injection, 0.25 mg/vial kit. The label states it contains one single-dose vial with lyophilized powder for reconstitution, one pre-filled syringe with diluent, one 20-gauge needle, and one 27-gauge needle. Store refrigerated at 2-8°C (36-46°F). Manufactured for Fresenius Kabi USA, LLC, Lake Zurich, IL, made in India. Includes barcode and storage instructions.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Cetrorelix Acetate for Injection 0.25 mg/vial kit by Fresenius Kabi USA, LLC. The packaging states it contains a single-dose vial with lyophilized powder, a pre-filled syringe with diluent, and two needles (20-gauge and 27-gauge). Instructions specify subcutaneous use only, refrigerated storage at 2-8°C, and that the product is sterile and for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.